Stay updated on PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A new publication citation has been added to the Publications section. It references a Nat Commun 2026 article on Copanlisib and Nivolumab in MSS colorectal cancer, expanding the study's bibliographic references.
    Difference
    0.0%
    Check dated 2026-08-01T09:07:16.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page revision was updated to v3.6.4, replacing the previous v3.6.3. This reflects an update to the page's revision metadata rather than changes to study data.
    Difference
    0.0%
    Check dated 2026-07-25T05:23:46.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.2 to v3.6.3, signaling a newer version of the page template or backend update. This change does not modify study content, eligibility criteria, or results.
    Difference
    0.0%
    Check dated 2026-07-03T21:47:35.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added to replace the previous v3.6.0 in the page footer, signaling a new version of the page. This likely reflects minor updates to content or formatting rather than substantive changes to the study information.
    Difference
    0.0%
    Check dated 2026-06-26T20:50:13.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    The study record now displays 'No longer looking for participants', indicating recruitment has closed. New navigational/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading was reformatted from 'Intervention / Treatment' to 'Intervention/Treatment'.
    Difference
    0.4%
    Check dated 2026-06-12T15:39:36.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    Page revision label updated from v3.5.4 to v3.5.5, reflecting a newer build version. This metadata-level change does not alter the study details, eligibility criteria, or results information presented on the page.
    Difference
    0.0%
    Check dated 2026-06-05T11:22:50.000Z thumbnail image

Stay in the know with updates to PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PI3Kinase Inhibition and Nivolumab in Solid Tumors Clinical Trial page.